{"status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved.", "response": {"docs": [{"word_count": 1626, "slideshow_credits": null, "multimedia": [], "news_desk": "Health & Fitness", "pub_date": "2004-12-28T00:00:00Z", "source": "The New York Times", "web_url": "http://www.nytimes.com/2004/12/28/health/policy/28pain.html", "blog": [], "_id": "4fd24a448eb7c8105d7e7e74", "headline": {"main": "Vioxx. Celebrex. Now Aleve. What's a Patient to Think?"}, "subsection_name": null, "abstract": null, "section_name": "Health", "byline": {"original": "By ANAHAD O'CONNOR", "person": [{"rank": 1, "firstname": "Anahad", "lastname": "O'CONNOR", "role": "reported", "organization": ""}]}, "print_page": "5", "document_type": "article", "type_of_material": "News", "keywords": [{"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "RECALLS AND BANS OF PRODUCTS", "name": "subject"}], "lead_paragraph": "When Audrey Eisen flicked her computer on last Monday night and read the news that the painkiller Aleve had been linked to heart attacks, she winced in disbelief. Ms. Eisen, 64, a retired professor who lives in New York, had just returned from her drugstore with a package of Aleve. Her pharmacist allowed her to return it the next morning, no questions asked.", "snippet": "Many Americans who have relied on pain pills say their faith in the system intended to protect them has been eroded."}], "meta": {"offset": 0, "hits": 1, "time": 41}}}